Hemangioma cavernoso difuso rectal

Hermosa, Alicia Ruiz de la; Ortúzar, Jaime Zorrilla; Valle-Hernández, Emilio Del

doi:10.24875/ciru.20000746

Cited by 4 publications

(4 citation statements)

References 12 publications

(33 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…MRI shows a typical heterogeneous high signal in T2 images, and "venous stone" without a signal can be seen. [10] Various treatment options are available for rectal cavernous hemangiomas including drug therapy, sclerotherapy, and surgical resection. Medication can temporarily stop bleeding, but the lesion cannot be eliminated and the symptoms recur.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Endoscopic injection of lauromacrogol foam sclerotherapy for rectal cavernous hemangioma: A case report

Chen,

Jiang

et al. 2024

Medicine

View full text Add to dashboard Cite

Rationale: Rectal cavernous hemangioma is a rare, benign vascular disease that seldom causes lower gastrointestinal bleeding, characterized by a high rate of misdiagnosis and missed diagnoses. Surgical treatment is considered to be relatively effective; however, it is accompanied by certain employed in the treatment of superficial hemangioma, boasting the advantages of minimally invasive surgery, including safety, effectiveness, reduced trauma, and rapid recovery. However, there is a lack of literature regarding the application of foam sclerosing agents for gastrointestinal hemangiomas. Case concerns: We present a case of a 60-year-old male who was admitted to our hospital with a history of recurrent hematochezia for >1 year and worsening symptoms for 1 week. The patient's medical history was unremarkable. Diagnoses: Following colonoscopy, nuclear magnetic resonance imaging, computed tomography, and other examinations, the final diagnosis was rectal cavernous hemangioma. Interventions: Due to the patient’s refusal of surgery, endoscopic foam sclerotherapy using a lauromacrogol injection was performed after obtaining informed consent from the patient and their relatives. Outcomes: Post-sclerotherapy, hematochezia symptoms ceased, and no adverse reactions were observed. Two months later, colonoscopy and nuclear magnetic resonance imaging showed that the hemangioma had almost completely disappeared, with only a small amount of tumor remnants, yielding a satisfactory curative effect. Conclusion: Our findings indicate that endoscopic injection of a lauromacrogol foam sclerosing agent is a safe, effective, and minimally invasive treatment option for gastrointestinal cavernous hemangiomas.

show abstract

Section: Discussionmentioning

confidence: 99%

“…MRI shows a typical heterogeneous high signal in T2 images, and “venous stone” without a signal can be seen. [10]…”

Section: Discussionmentioning

confidence: 99%

Endoscopic injection of lauromacrogol foam sclerotherapy for rectal cavernous hemangioma: A case report

Chen,

Jiang

et al. 2024

Medicine

View full text Add to dashboard Cite

show abstract

“…These rare malformations of distal colon and rectum were described in 1839 by Philips and only 351 cases were reported in Medline database till 2021 [ 19 , 20 ]. In patients with anemia and occult, minimal, or fulminant rectal bleeding, the endoscopy can reveal unspecific lesions, from purple mucosa, submucosal petechiae, or fluid-filled cystic structures, which induce prolonged bleeding, after biopsy, till circumferential thickening of the GI wall and formation of phleboliths in 29-50% of the cases [ 19 , 20 ]. Differential diagnosis includes hemorrhoids, pneumatosis or melanosis coli, ulcerative colitis, proctitis, and carcinoma [ 19 , 20 ].…”

Section: Vascular Hamartomasmentioning

confidence: 99%

“…In patients with anemia and occult, minimal, or fulminant rectal bleeding, the endoscopy can reveal unspecific lesions, from purple mucosa, submucosal petechiae, or fluid-filled cystic structures, which induce prolonged bleeding, after biopsy, till circumferential thickening of the GI wall and formation of phleboliths in 29-50% of the cases [ 19 , 20 ]. Differential diagnosis includes hemorrhoids, pneumatosis or melanosis coli, ulcerative colitis, proctitis, and carcinoma [ 19 , 20 ].…”

Section: Vascular Hamartomasmentioning

confidence: 99%

Nonpolypous Hamartomas of the Gastrointestinal Tract: An Updated Review on Classification, Denominations, and Clinical Management

Gurzu

Jung

2022

Journal of Oncology

View full text Add to dashboard Cite

Purpose. To perform the first systematic report about histological subtypes of nonpolypous hamartomas of the gastrointestinal (GI) tract, from esophagus to anal canal. Design. From over 19,000 studies about hamartomas, most of them published as case series or case presentations, we have selected the most representative ones for the GI tract, excluding polyposis syndromes. To have a whole picture of these hamartomas, all of the data were combined with the personal experience of the authors who are GI pathologists. Results. The examined articles showed predominance of vascular and combined vascular and mesenchymal hamartomas. Arteriovenous hamartomas or Brunner gland hamartomas are mainly diagnosed in the small intestine, with preponderance for duodenum. Other malformations such cavernous hamartomas are more specific for the colorectal segments, whereas chondromatous hamartomas or those derived from the neural ectoderm were mostly reported in the esophagus. As newly recognized entities were admitted in the last years, misdiagnosis is frequent, and the best therapeutic approach is far to be known. Conclusion. Even rare, hamartomas of the GI tract need to be differentiated from tumors and familial polyposis syndromes. Knowing their proper denominations and possible complications is valuable for gastroenterologists, pathologists, and surgeons, to be aware in the differential diagnosis.

show abstract